litlas
ログインアカウント作成

Peter McLaughlin

1976–2023 年に発表

90
論文数
19,411
被引用数
80
h 指数
87
i10 指数

被引用数

Peter McLaughlin の年別被引用数1977 年: 被引用 3 件1978 年: 被引用 5 件1979 年: 被引用 4 件1980 年: 被引用 6 件1981 年: 被引用 10 件1982 年: 被引用 4 件1983 年: 被引用 5 件1984 年: 被引用 4 件1985 年: 被引用 3 件1986 年: 被引用 6 件1987 年: 被引用 9 件1988 年: 被引用 8 件1989 年: 被引用 16 件1990 年: 被引用 11 件1991 年: 被引用 26 件1992 年: 被引用 16 件1993 年: 被引用 36 件1994 年: 被引用 38 件1995 年: 被引用 41 件1996 年: 被引用 25 件1997 年: 被引用 30 件1998 年: 被引用 42 件1999 年: 被引用 53 件2000 年: 被引用 94 件2001 年: 被引用 105 件2002 年: 被引用 114 件2003 年: 被引用 161 件2004 年: 被引用 150 件2005 年: 被引用 187 件2006 年: 被引用 171 件2007 年: 被引用 182 件2008 年: 被引用 188 件2009 年: 被引用 190 件2010 年: 被引用 188 件2011 年: 被引用 146 件2012 年: 被引用 126 件2013 年: 被引用 114 件2014 年: 被引用 126 件2015 年: 被引用 100 件2016 年: 被引用 69 件2017 年: 被引用 92 件2018 年: 被引用 68 件2019 年: 被引用 215 件2020 年: 被引用 212 件2021 年: 被引用 179 件2022 年: 被引用 100 件2023 年: 被引用 70 件2024 年: 被引用 80 件2025 年: 被引用 42 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,520 件、この内訳の 32.5%イギリス: 引用元論文 339 件、この内訳の 7.2%ドイツ: 引用元論文 312 件、この内訳の 6.7%フランス: 引用元論文 301 件、この内訳の 6.4%イタリア: 引用元論文 296 件、この内訳の 6.3%カナダ: 引用元論文 192 件、この内訳の 4.1%スペイン: 引用元論文 151 件、この内訳の 3.2%オーストラリア: 引用元論文 147 件、この内訳の 3.1%中国: 引用元論文 136 件、この内訳の 2.9%スイス: 引用元論文 126 件、この内訳の 2.7%オランダ: 引用元論文 124 件、この内訳の 2.7%日本: 引用元論文 106 件、この内訳の 2.3%
0%32.5%その他 19.9%

機関

分野

  • Medicine81.6%
  • Biochemistry, Genetics and Molecular Biology7%
  • Immunology and Microbiology5.7%
  • Neuroscience1.2%
  • Materials Science1%
  • Agricultural and Biological Sciences0.8%
  • その他2.7%

トピック

  • Lymphoma Diagnosis and Treatment16.9%
  • Chronic Lymphocytic Leukemia Research7.9%
  • Viral-associated cancers and disorders4.7%
  • CAR-T cell therapy research3.9%
  • CNS Lymphoma Diagnosis and Treatment3.9%
  • Monoclonal and Polyclonal Antibodies Research3.4%
  • その他59.3%

共著者

全論文

検索で開く
  1. Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project

    著者: Massimo Federico, Monica Bellei, Luigi Marcheselli, Stefano Luminari, Armando López‐Guillermo, Umberto Vitolo, Barbara Pro, Stefano Pileri, Alessandro Pulsoni, Pierre Soubeyran, Sergio Cortelazzo, Giovanni Martinelli, Maurizio Martelli, Luigi Rigacci, Luca Arcaini, Francesco Di Raimondo, Francesco Merli, Elena Sabattini, Peter McLaughlin, Philippe Solal‐Céligny - Journal of Clinical Oncology 2009 被引用: 751

  2. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

    著者: Peter McLaughlin, A.J. Grillo-López, Brian K. Link, Ronald Levy, M. S. Czuczman, Michael E. Williams, Meyer R. Heyman, Isabelle Bence‐Bruckler, Christine A. White, Fernando Cabanillas, Vinay Jain, Anthony D. Ho, John Lister, Ken Wey, Diying Shen, B.K. Dallaire - Journal of Clinical Oncology 1998 被引用: 2,759

  3. Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial

    著者: Michael Wang, Luis Fayad, Nicolaus A. Wagner‐Bartak, Liang Zhang, Fredrick Hagemeister, Sattva S. Neelapu, Felipe Samaniego, Peter McLaughlin, Michelle A. Fanale, Anas Younes, Fernando Cabanillas, Nathan Fowler, Kate J. Newberry, Luhong Sun, Ken H. Young, Richard E. Champlin, Larry W. Kwak, Lei Feng, Maria Badillo, Maria Teresa Bejarano, Kimberly Hartig, Wendy Chen, Yi‐Ming Chen, Catriona Byrne, Neda Bell, Jerome B. Zeldis, Jorge Romaguera - The Lancet Oncology 2012 被引用: 297

  4. Nontypeable Haemophilus influenzae Induces Sustained Lung Oxidative Stress and Protease Expression

    著者: Paul T. King, Roleen Sharma, Kim M. O’Sullivan, Stavros Selemidis, Steven Lim, Naghmeh Radhakrishna, Camden Lo, Jyotika D. Prasad, Judy M. Callaghan, Peter McLaughlin, Michael Farmer, Daniel Steinfort, Barton R. Jennings, James Ngui, Bradley Broughton, Belinda J. Thomas, Ama‐Tawiah Essilfie, Michael J. Hickey, Peter W. Holmes, Philip M. Hansbro, Philip G. Bardin, Stephen R. Holdsworth - PLoS ONE 2015 被引用: 80

  5. The Novel Cannabinoid CB1 Receptor Neutral Antagonist AM4113 Suppresses Food Intake and Food-Reinforced Behavior but Does not Induce Signs of Nausea in Rats

    著者: Kelly S. Sink, Peter McLaughlin, Jodi Wood, C. Brown, Pusheng Fan, Kiran Vemuri, Yan Pang, Teresa Olzewska, Ganesh A. Thakur, A. Makriyannis, Linda A. Parker, John D. Salamone - Neuropsychopharmacology 2007 被引用: 160

  6. Watchful Waiting in Low–Tumor Burden Follicular Lymphoma in the Rituximab Era: Results of an F2-Study Database

    著者: Philippe Solal‐Céligny, Monica Bellei, Luigi Marcheselli, Emanuela Anna Pesce, Stefano Pileri, Peter McLaughlin, Stefano Luminari, Barbara Pro, Silvia Montoto, Andrés J.M. Ferreri, Éric Deconinck, Nöel Milpied, Leo I. Gordon, Massimo Federico - Journal of Clinical Oncology 2012 被引用: 129

  7. Neuroscience explanations really do satisfy: A systematic review and meta-analysis of the seductive allure of neuroscience

    著者: Elizabeth Bennett, Peter McLaughlin - Public Understanding of Science 2023 被引用: 18

  8. Other Malignancies in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

    著者: Apostolia M. Tsimberidou, Sijin Wen, Peter McLaughlin, Susan O’Brien, William G. Wierda, Susan Lerner, Sara S. Strom, Emil J. Freireich, L. Jeffrey Medeiros, Hagop M. Kantarjian, Michael J. Keating - Journal of Clinical Oncology 2008 被引用: 241

  9. Long-term results with radiotherapy for stage I–II follicular lymphomas

    著者: Richard B. Wilder, Dan Jones, Susan L. Tucker, Lillian M. Fuller, Chul S Ha, Peter McLaughlin, Mark A. Hess, Fernando Cabanillas, James D. Cox - International Journal of Radiation Oncology*Biology*Physics 2001 被引用: 179

  10. Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival

    著者: A H Sarris, K. O. Kliche, P. Pethambaram, A. Preti, S. Tucker, Clotilde M. Jackow, Osvaldo Daniel Messina, William Pugh, Fredrick B. Hagemeister, Peter McLaughlin, Maria Alma Rodriguez, Jorge Romaguera, Herbert A. Fritsche, Thomas E. Witzig, Madeleine Duvic, M Andreeff, Fernando Cabanillas - Annals of Oncology 1999 被引用: 163

  11. Phase I Study of a Novel Oral Janus Kinase 2 Inhibitor, SB1518, in Patients With Relapsed Lymphoma: Evidence of Clinical and Biologic Activity in Multiple Lymphoma Subtypes

    著者: Anas Younes, Jorge Romaguera, Michelle A. Fanale, Peter McLaughlin, Frederick Hagemeister, Amanda Copeland, Sattva S. Neelapu, Larry W. Kwak, Jatin J. Shah, Silvana de Castro Faria, Stefan Hart, Jeanette M. Wood, Ramesh Jayaraman, Kantharaj Ethirajulu, Joy Zhu - Journal of Clinical Oncology 2012 被引用: 139

  12. Association of serum Rituximab (IDEC–C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin’s lymphoma

    著者: Neil L. Berinstein, A.J. Grillo-López, Christine A. White, Isabelle Bence‐Bruckler, David G. Maloney, M. S. Czuczman, D. Green, J. Rosenberg, Peter McLaughlin, Diying Shen - Annals of Oncology 1998 被引用: 523

  13. ESHAP-an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study.

    著者: William S. Velasquez, Peter McLaughlin, S Tucker, Fredrick B. Hagemeister, F Swan, Maria Alma Rodriguez, Jorge Romaguera, Edward Rubenstein, Fernando Cabanillas - Journal of Clinical Oncology 1994 被引用: 430

  14. Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial

    著者: Nathan Fowler, R. Eric Davis, Seema Rawal, Loretta J. Nastoupil, Fredrick B. Hagemeister, Peter McLaughlin, Larry W. Kwak, Jorge Romaguera, Michelle A. Fanale, Luis Fayad, Jason R. Westin, Jatin J. Shah, Robert Z. Orlowski, Michael Wang, Francesco Turturro, Yasuhiro Oki, Linda Claret, Lei Feng, Veerabhadran Baladandayuthapani, Tariq Muzzafar, Kenneth Y. Tsai, Felipe Samaniego, Sattva S. Neelapu - The Lancet Oncology 2014 被引用: 263

  15. Temsirolimus Has Activity in Non–Mantle Cell Non-Hodgkin's Lymphoma Subtypes: The University of Chicago Phase II Consortium

    著者: Sonali M. Smith, Koen van Besien, Theodore Karrison, Janet Dancey, Peter McLaughlin, Anas Younes, Scott E. Smith, Patrick J. Stiff, Eric P. Lester, Sanjiv Modi, L. Austin Doyle, Everett E. Vokes, Barbara Pro - Journal of Clinical Oncology 2010 被引用: 208

  16. Long-term reduction in sperm count after chemotherapy with and without radiation therapy for non-Hodgkin's lymphomas.

    著者: Rodger M. Pryzant, Marvin L. Meistrich, Gene Wilson, B Brown, Peter McLaughlin - Journal of Clinical Oncology 1993 被引用: 169

  17. Cannabinoid CB1 receptor inverse agonists and neutral antagonists: Effects on food intake, food-reinforced behavior and food aversions

    著者: John D. Salamone, Peter McLaughlin, Kelly S. Sink, Alexandros Makriyannis, Linda A. Parker - Physiology & Behavior 2007 被引用: 133

  18. Phase II multicenter study of oblimersen sodium, a Bcl‐2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B‐cell non‐Hodgkin lymphoma

    著者: Barbara Pro, Brian Leber, Mitchell R. Smith, Luis Fayad, Jorge Romaguera, Fredrick B. Hagemeister, Maria Alma Rodriguez, Peter McLaughlin, Felipe Samaniego, James A. Zwiebel, Adriana López, Larry W. Kwak, Anas Younes - British Journal of Haematology 2008 被引用: 105

  19. Encouraging activity for R-CHOP in advanced stage nodular lymphocyte–predominant Hodgkin lymphoma

    著者: Michelle A. Fanale, Chan Y. Cheah, Amy Rich, L. Jeffrey Medeiros, Chao-Ming Lai, Yasuhiro Oki, Jorge Romaguera, Luis Fayad, Fredrick B. Hagemeister, Felipe Samaniego, Maria Alma Rodriguez, Sattva S. Neelapu, Hun Ju Lee, Loretta J. Nastoupil, Nathan Fowler, Francesco Turturro, Jason R. Westin, Michael Wang, Peter McLaughlin, Chelsea C. Pinnix, Sarah A. Milgrom, Bouthaina S. Dabaja, Sandra B. Horowitz, Anas Younes - Blood 2017 被引用: 88

  20. Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma

    著者: Bita Esmaeli, Peter McLaughlin, Barbara Pro, Felipe Samaniego, Isis Gayed, Fredrick B. Hagemeister, Jorge Romaguera, Fernando Cabanillas, Sattva S. Neelapu, R. Banay, Luis Fayad, M. Wayne Saville, Larry W. Kwak - Annals of Oncology 2009 被引用: 88

  21. Follicular lymphoma international prognostic index.

    著者: Philippe Solal-Céligny, Pascal Roy, Philippe Colombat, Josephine M White, Jim O Armitage, Reyes Arranz-Sáez, Wing Y Au, Monica Bellei, Pauline Brice, Dolores Caballero, Bertrand Coiffier, E. Conde-Garcia, Chantal Doyen, Massimo Federico, Richard I Fisher, Javier F Garcia-Conde, Cesare Guglielmi, Anton Hagenbeek, Corinne Haïoun, Michael LeBlanc, Andrew Lister, Armando López‐Guillermo, Peter McLaughlin, Nöel Milpied, Pierre Morel, Nicolas Mounier, Stephen J Proctor, Ama Rohatiner, Paul Smith, Pierre Soubeyran, Hervé Tilly, Umberto Vitolo, Pier Luigi Zinzani, Emanuele Zucca, Emili Montserrat - Blood 2004 被引用: 1,532

  22. Rituximab Anti-CD20 Monoclonal Antibody Therapy in Non-Hodgkin’s Lymphoma: Safety and Efficacy of Re-Treatment

    著者: Thomas A. Davis, Antonio J Grillo-López, Christine A. White, Peter McLaughlin, Myron S. Czuczman, Brian K. Link, David G. Maloney, Robin Weaver, J. Rosenberg, Ronald Levy - Journal of Clinical Oncology 2000 被引用: 689

  23. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)

    著者: WS Velasquez, Fernando Cabanillas, P. Salvador, Peter McLaughlin, Michael Fridrik, S Tucker, Sundar Jagannath, FB Hagemeister, JR Redman, F Swan - Blood 1988 被引用: 581

  24. Phase II Study of Proteasome Inhibitor Bortezomib in Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

    著者: André Goy, Anas Younes, Peter McLaughlin, Barbara Pro, Jorge Romaguera, Frederick Hagemeister, Luis Fayad, Nam H. Dang, Felipe Samaniego, Michael Wang, Kristine Broglio, Barry I. Samuels, Frédéric Gilles, Andreas H. Sarris, Susan Hart, Elizabeth Trehu, David P. Schenkein, Fernando Cabanillas, Alma María Rodríguez - Journal of Clinical Oncology 2004 被引用: 527